Investor directorySyncona
Syncona invests in life science companies across various therapeutic areas and stages of development.
What they invest in
Geographies
United Kingdom
The facts
- Typical cheque
- €9M – €30M
- Headquarters
- London, United Kingdom
- Founded
- 2012
Portfolio companies
More portfolio companies
SwanBio TherapeuticsGyroscopeNightstaRxAutolus (NAS: AUTL)Achilles TherapeuticsALTx TherapeuticsOrbit BiomedicalRe-Aim TherapeuticsBACITAutolus TherapeuticsBeacon TherapeuticsSpur TherapeuticsiOncturaQuell TherapeuticsAnaveonMosaic TherapeuticsResolution TherapeuticsForcefield TherapeuticsOMass TherapeuticsKesmalea TherapeuticsYellowstone BiosciencesSlingshot TherapeuticsGyroscope TherapeuticsBlue Earth
and 5 more
Recent rounds
OMass Therapeutics
€275 millionSeries CBiotech & PharmaBain Capital Life SciencesleadForbionleadNovo HoldingsleadSynconaJanus Henderson InvestorsSV Health Investors · +5 more in the source
Rounds Syncona took part in, as reported by the linked articles. See who else is investing right now.
Questions founders ask
- How much does Syncona typically invest?
- Syncona states a typical cheque of €9M – €30M.
- Which stages does Syncona invest in?
- Syncona invests at Series A and Seed.
- Where is Syncona based?
- Syncona is headquartered in London, United Kingdom.
Search investors like this in Claude — no account, no sign-in. Open in Claude
Are you Syncona? Tell us what to correct and we will update it — or ask us to remove the entry.